12-19440152-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_153207.5(AEBP2):c.453T>A(p.Asp151Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,497,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153207.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AEBP2 | NM_153207.5 | c.453T>A | p.Asp151Glu | missense_variant | 1/8 | ENST00000266508.14 | NP_694939.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AEBP2 | ENST00000266508.14 | c.453T>A | p.Asp151Glu | missense_variant | 1/8 | 1 | NM_153207.5 | ENSP00000266508 | ||
AEBP2 | ENST00000398864.7 | c.453T>A | p.Asp151Glu | missense_variant | 1/9 | 1 | ENSP00000381840 | P1 | ||
AEBP2 | ENST00000538425.5 | c.-16-22358T>A | intron_variant | 4 | ENSP00000444255 | |||||
AEBP2 | ENST00000541908.5 | c.-16-22358T>A | intron_variant | 3 | ENSP00000437983 |
Frequencies
GnomAD3 genomes AF: 0.000163 AC: 24AN: 147238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 21AN: 101318Hom.: 0 AF XY: 0.000143 AC XY: 8AN XY: 55802
GnomAD4 exome AF: 0.000247 AC: 334AN: 1350692Hom.: 0 Cov.: 35 AF XY: 0.000236 AC XY: 157AN XY: 665370
GnomAD4 genome AF: 0.000163 AC: 24AN: 147238Hom.: 0 Cov.: 32 AF XY: 0.000195 AC XY: 14AN XY: 71808
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.453T>A (p.D151E) alteration is located in exon 1 (coding exon 1) of the AEBP2 gene. This alteration results from a T to A substitution at nucleotide position 453, causing the aspartic acid (D) at amino acid position 151 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at